[Predictive factors for sequelae of bronchitis obliterans in refractory Mycoplasma pneumoniae pneumonia]

J H Liu1, J R Liu1, X L Tang1

  • 1Department of No.2 Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Disease, National Center for Children's Health, Beijing 100045, China.

Insights

Longer fever duration and elevated C-reactive protein (CRP) levels predict the development of bronchitis obliterans in children with refractory Mycoplasma pneumoniae pneumonia (RMPP). Early identification of these risk factors aids in recognizing children at risk for this serious complication.

Area of Science:

  • Pediatric Respiratory Medicine
  • Infectious Diseases
  • Pulmonology

Context:

  • Refractory Mycoplasma pneumoniae pneumonia (RMPP) can lead to long-term respiratory complications.
  • Bronchitis obliterans is a significant sequela of RMPP, impacting lung function.
  • Identifying predictive factors for RMPP-associated bronchitis obliterans is crucial for timely intervention.

Purpose:

  • To investigate the predictive factors for the development of bronchitis obliterans in children with RMPP.
  • To identify clinical and laboratory markers associated with bronchitis obliterans sequelae.
  • To explore the utility of C-reactive protein (CRP) and lactate dehydrogenase (LDH) levels in predicting this complication.

Summary:

  • A retrospective study of 230 RMPP patients identified prolonged fever (≥10 days), elevated CRP (≥137 mg/L), and increased LDH as significant risk factors for bronchitis obliterans.
  • Multivariate analysis confirmed fever duration, CRP, and LDH as independent predictors.
  • ROC curve analysis demonstrated the predictive value of CRP (sensitivity 82.1%, specificity 80.1%) and LDH for bronchitis obliterans.

Impact:

  • Findings facilitate early identification of RMPP patients at high risk for developing bronchitis obliterans.
  • Establishes key clinical and laboratory indicators for predicting this severe sequela.
  • Supports proactive management strategies to mitigate long-term respiratory impairment in children with RMPP.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
391
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
380
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
307
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
260